Cure H - Search Results

1

[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer].

Mouret-Reynier MA, Abrial C, Leheurteur M, Durando X, Van Praagh I, Gimbergues P, Achard JL, Ferrière JP, Cure H, Chollet P. Mouret-Reynier MA, et al. Among authors: cure h. Bull Cancer. 2006 Nov;93(11):1121-9. Bull Cancer. 2006. PMID: 17145582 Free article. Review. French.

2

Neoadjuvant FEC 100 for operable breast cancer: eight-year experience at Centre Jean Perrin.

Mouret-Reynier MA, Abrial CJ, Ferrière JP, Amat S, Curé HD, Kwiatkowski FG, Feillel VA, Lebouëdec G, Penault-Llorca FM, Chollet PJ. Mouret-Reynier MA, et al. Clin Breast Cancer. 2004 Oct;5(4):303-7. doi: 10.3816/cbc.2004.n.035. Clin Breast Cancer. 2004. PMID: 15507178 Clinical Trial.

3

Efficacy of a primary chemotherapy regimen combining vinorelbine, epirubicin, and methotrexate (VEM) as neoadjuvant treatment in 89 patients with operable breast cancer.

Van Praagh I, Cure H, Leduc B, Charrier S, Le Bouedec G, Achard JL, Ferriere JP, Feillel V, De Latour M, Dauplat J, Chollet P. Van Praagh I, et al. Among authors: cure h. Oncologist. 2002;7(5):418-23. doi: 10.1634/theoncologist.7-5-418. Oncologist. 2002. PMID: 12401904 Free article.

4

Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy.

Curé H, Amat S, Penault-Llorca F, le Bouëdec G, Ferrière JP, Mouret-Reynier MA, Kwiatkowski F, Feillel V, Dauplat J, Chollet P. Curé H, et al. Breast Cancer Res Treat. 2002 Nov;76(1):37-45. doi: 10.1023/a:1020274709327. Breast Cancer Res Treat. 2002. PMID: 12408374

5

[Place of anatomopathology in evaluation of response to neoadjuvant chemotherapy. Prognostic and predictive markers: example of breast cancer].

Abrial C, Bouchet-Mishellany F, Raoelfils I, Cayre A, Curé H, Chollet P, Penault-Llorca F. Abrial C, et al. Among authors: cure h. Bull Cancer. 2006 Jul;93(7):663-8. Bull Cancer. 2006. PMID: 16873074 Free article. French.

6

Sequential addition of an anthracycline-based regimen to docetaxel as neoadjuvant chemotherapy in patients with operable breast cancer.

Amat S, Mouret-Reynier MA, Penault-Llorca F, Leheurteur M, Delva R, Coudert B, Leduc B, Dauplat J, Curé H, Chollet P. Amat S, et al. Among authors: cure h. Clin Breast Cancer. 2006 Aug;7(3):262-9. doi: 10.3816/CBC.2006.n.039. Clin Breast Cancer. 2006. PMID: 16942644 Clinical Trial.

7

Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer.

Chollet P, Abrial C, Tacca O, Mouret-Reynier MA, Leheurteur M, Durando X, Curé H. Chollet P, et al. Among authors: cure h. Clin Breast Cancer. 2006 Oct;7(4):336-8. doi: 10.3816/CBC.2006.n.047. Clin Breast Cancer. 2006. PMID: 17092402

8

Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer.

Penault-Llorca F, Abrial C, Mouret-Reynier MA, Raoelfils I, Durando X, Leheurteur M, Gimbergues P, Tortochaux J, Curé H, Chollet P. Penault-Llorca F, et al. Among authors: cure h. Oncologist. 2007 Apr;12(4):390-6. doi: 10.1634/theoncologist.12-4-390. Oncologist. 2007. PMID: 17470681 Free article.

9

Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy.

Tacca O, Penault-Llorca F, Abrial C, Mouret-Reynier MA, Raoelfils I, Durando X, Achard JL, Gimbergues P, Curé H, Chollet P. Tacca O, et al. Among authors: cure h. Oncologist. 2007 Jun;12(6):636-43. doi: 10.1634/theoncologist.12-6-636. Oncologist. 2007. PMID: 17602055 Free article.

10

Is it important to adapt neoadjuvant chemotherapy to the visible clinical response? An open randomized phase II study comparing response-guided and standard treatments in HER2-negative operable breast cancer.

Wang-Lopez Q, Mouret-Reynier MA, Savoye AM, Abrial C, Kwiatkowski F, Garbar C, DuBray-Longeras P, Eymard JC, Lebouedec G, Vanpraagh I, Penault-Llorca F, Chollet P, Cure H. Wang-Lopez Q, et al. Among authors: cure h. Oncologist. 2015 Mar;20(3):243-4. doi: 10.1634/theoncologist.2014-0400. Epub 2015 Jan 30. Oncologist. 2015. PMID: 25637380 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters